N-((1H-BEnzo[d][1,2,3]triazol-1-yl)methyl)-3-nitroaniline

Catalog No. :
ACLCLP797
CAS No. :
122062-65-1
Molecular Formula :
C13H11N5O2
Molecular Weight :
269.26

IUPAC Name:N-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)-3-nitroaniline

N-((1H-BEnzo[d][1,2,3]triazol-1-yl)methyl)-3-nitroaniline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$232.00Login to see priceInquiryInquiry
1g95%$697.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((1H-BEnzo[d][1,2,3]triazol-1-yl)methyl)-3-nitroaniline
IUPAC NameN-((1H-benzo[d][1,2,3]triazol-1-yl)methyl)-3-nitroaniline
MDL No.MFCD00183538
Molecular FormulaC13H11N5O2
Molecular Weight269.26
SMILES[O-][N+](C1=CC=CC(NCN2N=NC3=C2C=CC=C3)=C1)=O
InChI KeyFSJMZFUALNDQSF-UHFFFAOYSA-N
SynonymN-(benzotriazol-1-ylmethyl)-3-nitroaniline;N-((1H-Benzo[d][1,2,3]triazol-1-yl)methyl)-3-nitroaniline
CAS No.122062-65-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLCLP797 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIODH642 route compound structure diagram
    ACIODH64233240-96-9 In Stock
  2. Plus
  3. ACPMFB928 route compound structure diagram
    ACPMFB92872773-04-7 In Stock
  4. Then
  5. ACLCLP797 route product structure diagram
    ACLCLP797122062-65-1
Inquiry

2. ACLCLP797 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIODH642 route compound structure diagram
    ACIODH64233240-96-9 In Stock
  2. Plus
  3. ACCYAB461 route compound structure diagram
    ACCYAB46128539-02-8 In Stock
  4. Then
  5. ACLCLP797 route product structure diagram
    ACLCLP797122062-65-1
Inquiry

Comments (0)